Thomas Wicks

Thomas is responsible for tracking regulatory and market trends that shape TrialScope’s clinical trial disclosure and transparency solutions. He has more than 23 years of experience with performance and content management solutions, specializing in applications for life sciences such as clinical trial disclosure, structured product labeling and submissions management. Thomas has been focused on trial transparency since 2007.

  • The unique challenges of global clinical trial transparency

    The unique challenges of global clinical trial transparency

    TrialScope Chief Strategy Officer Thomas Wicks takes a look at the inherent challenges of global clinical trial transparency.

    Read Article
  • Meeting the EU CTR Compliance Challenge Head-On

    Meeting the EU CTR Compliance Challenge Head-On

    Looking at public data on EU CTR as of July 16, a TrialScope analysis found a total of the over 16,000 clinical trials that ended more than 12 months earlier, only around 10,000 had results posted.

    Read Article
  • 2 Steps for Correcting Non-compliance with EU Disclosure Regulations

    2 Steps for Correcting Non-compliance with EU Disclosure Regulations

    On the EU CTR registry, many clinical trial results unavailable, and it appears many studies were registered but never updated. Here's a two-step process on how to correct this non-compliance.

    Read Article
  • Survey Reveals Plain-Language Commitments Still Evolving

    Survey Reveals Plain-Language Commitments Still Evolving

    Results of a recent TrialScope survey reveal that most sponsors are committing to providing plain-language summaries for Phase 2 – 4 clinical trials, with some extending to Phase 1 studies.

    Read Article
  • loading
    Loading More...